These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8460331)

  • 1. [Hemoccult II].
    Rogez E
    Rev Infirm; 1993 Jan; 43(2):61-2. PubMed ID: 8460331
    [No Abstract]   [Full Text] [Related]  

  • 2. Fecal occult blood testing: clinical value and limitations.
    Simon JB
    Gastroenterologist; 1998 Mar; 6(1):66-78. PubMed ID: 9531118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of fecal occult-blood screening on the incidence of colorectal cancer.
    Allison JE
    N Engl J Med; 2001 Mar; 344(13):1022; author reply 1023. PubMed ID: 11280326
    [No Abstract]   [Full Text] [Related]  

  • 4. Prospective comparative evaluation of an office-based rapid immunological test with a Guaiac-based fecal occult blood test for colorectal cancer screening in general population with average-risk.
    Shastri YM; Loitsch S; Nowak R; Povse N; Stein J
    Clin Lab; 2008; 54(9-10):385-7. PubMed ID: 19097496
    [No Abstract]   [Full Text] [Related]  

  • 5. Screening for colorectal cancer.
    Young GP
    Jpn J Cancer Res; 1996 Dec; 87(12):inside front cover. PubMed ID: 9045951
    [No Abstract]   [Full Text] [Related]  

  • 6. Screening for colorectal cancer. A comparison of 3 fecal occult blood tests.
    Levin B; Hess K; Johnson C
    Arch Intern Med; 1997 May; 157(9):970-6. PubMed ID: 9140267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Green-coloured results on guaiac-based faecal occult blood testing should be considered positive.
    Skitek M
    Ann Clin Biochem; 2005 May; 42(Pt 3):234-5; author reply 235. PubMed ID: 15949162
    [No Abstract]   [Full Text] [Related]  

  • 8. [Informative value of Hemoccult test according to the number of positive slides in mass screening of colorectal cancer].
    Tazi MA; Faivre J; Lejeune C; Dassonville F; Benhamiche AM
    Bull Cancer; 1998 Dec; 85(12):1055-9. PubMed ID: 9917557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for colorectal cancer with Hemoccult-II in the average risk population.
    Kronborg O
    Gastroenterol Clin Biol; 1998 Mar; 22(3 Suppl):S44-8. PubMed ID: 9762237
    [No Abstract]   [Full Text] [Related]  

  • 10. A 25-year follow-up of a population screened with faecal occult blood test in Finland.
    Malila N; Hakama M; Pukkala E
    Acta Oncol; 2007; 46(8):1103-6. PubMed ID: 17851857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experiences in providing a screening service for colorectal cancer from a pathology laboratory.
    Edwards JE; Williams JA; Thomas DW
    Pathology; 2004 Aug; 36(4):330-4. PubMed ID: 15370132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer testing.
    Griner SB
    Am Pharm; 1993 Sep; NS33(9):6, 8. PubMed ID: 8213484
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnostic yield in a biennial Hemoccult-II screening program compared to a once-only screening with flexible sigmoidoscopy and Hemoccult-II.
    Rasmussen M; Fenger C; Kronborg O
    Scand J Gastroenterol; 2003 Jan; 38(1):114-8. PubMed ID: 12608473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal occult blood testing: comparative evaluation of a two-hole versus a three-hole single slide test.
    Porschen R; Kruis W; Strohmeyer G
    Hepatogastroenterology; 1993 Apr; 40(2):191-3. PubMed ID: 8509054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Green-coloured results on guaiac-based faecal occult blood testing.
    Anthony T
    Ann Clin Biochem; 2005 May; 42(Pt 3):234; author reply 235. PubMed ID: 15949163
    [No Abstract]   [Full Text] [Related]  

  • 16. Is it reasonable to use faecal occult blood test for colorectal cancer screening?
    Musil D; Tillich J
    Acta Univ Palacki Olomuc Fac Med; 1999; 142():119-21. PubMed ID: 10743740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunological fecal occult blood test].
    Uchida K; Matsuse R; Miyachi N; Tomita S
    Nihon Rinsho; 1990 Feb; 48 Suppl():1276-85. PubMed ID: 2192121
    [No Abstract]   [Full Text] [Related]  

  • 18. Estimation of screening test (Hemoccult) sensitivity in colorectal cancer mass screening.
    Jouve JL; Remontet L; Dancourt V; Lejeune C; Benhamiche AM; Faivre J; Esteve J
    Br J Cancer; 2001 Jun; 84(11):1477-81. PubMed ID: 11384097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Performance of the Hemoccult test in the screening of colorectal cancer and adenoma. Results of 5 screening campaigns in Saône-et-Loire].
    Tazi MA; Faivre J; Lejeune C; Benhamiche AM; Dassonville F
    Gastroenterol Clin Biol; 1999 May; 23(5):475-80. PubMed ID: 10429850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does fecal occult blood test have a place for colorectal cancer screening in China in 2006?
    Sung J
    Am J Gastroenterol; 2006 Feb; 101(2):213-5. PubMed ID: 16454819
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.